Breast cancer is the most frequently diagnosed cancer in women and ranks second among
causes for cancer related death in women. Evidence in literature has shown that the past …

Background Breast cancer (BC) is a leading cause of cancer-related death in females
worldwide. Previous studies have demonstrated that matrix metalloproteinases (MMPs) play …

Background Breast cancer management depends on biomarkers including estrogen
receptor, progesterone receptor, and human epidermal growth factor receptor 2 …

Traditionally, intertumour heterogeneity in breast cancer has been documented in terms of
different histological subtypes, treatment sensitivity profiles, and clinical outcomes among …

Background Invasive lobular breast cancer (ILC) is the second most common type of breast
cancer after invasive breast cancer of no special type (NST), representing up to 15% of all …

Increased understanding of the molecular heterogeneity that is intrinsic to the various
subtypes of breast cancer will likely shape the future of breast cancer diagnosis, prognosis …

Invasive lobular carcinoma (ILC) demonstrates lower conspicuity on 18F-FDG PET than the
more common invasive ductal carcinoma. Other molecular imaging methods may be needed …

Background Breast cancer patients with tumors that are estrogen receptor (ER)-positive
and/or progesterone receptor (PR)-positive have lower risks of mortality after their diagnosis …

Purpose To determine how patients with infiltrating lobular carcinoma (ILC) differ from
patients with the more common infiltrating ductal carcinoma (IDC) with regard to patient and …

While most invasive breast cancers consist of carcinomas of the ductal type, about 10% are
invasive lobular carcinomas. Invasive lobular and ductal carcinomas differ with respect to …